1-Methyltryptophan treatment ameliorates high-fat diet-induced depression in mice through reversing changes in perineuronal nets

Juntao Hu,Shanshan Zhang,Haoran Wu,Leilei Wang,Yuwen Zhang,Hongyang Gao,Meihui Li,Hong Ren,Honglei Xiao,Kun Guo,Wensheng Li,Qiong Liu
DOI: https://doi.org/10.1038/s41398-024-02938-4
2024-05-31
Translational Psychiatry
Abstract:Depression and obesity are prevalent disorders with significant public health implications. In this study, we used a high-fat diet (HFD)-induced obese mouse model to investigate the mechanism underlying HFD-induced depression-like behaviors. HFD-induced obese mice exhibited depression-like behaviors and a reduction in hippocampus volume, which were reversed by treatment with an indoleamine 2,3-dioxygenase (IDO) inhibitor 1-methyltryptophan (1-MT). Interestingly, no changes in IDO levels were observed post-1-MT treatment, suggesting that other mechanisms may be involved in the anti-depressive effect of 1-MT. We further conducted RNA sequencing analysis to clarify the potential underlying mechanism of the anti-depressive effect of 1-MT in HFD-induced depressive mice and found a significant enrichment of shared differential genes in the extracellular matrix (ECM) organization pathway between the 1-MT-treated and untreated HFD-induced depressive mice. Therefore, we hypothesized that changes in ECM play a crucial role in the anti-depressive effect of 1-MT. To this end, we investigated perineuronal nets (PNNs), which are ECM assemblies that preferentially ensheath parvalbumin (PV)-positive interneurons and are involved in many abnormalities. We found that HFD is associated with excessive accumulation of PV-positive neurons and upregulation of PNNs, affecting synaptic transmission in PV-positive neurons and leading to glutamate-gamma-aminobutyric acid imbalances in the hippocampus. The 1-MT effectively reversed these changes, highlighting a PNN-related mechanism by which 1-MT exerts its anti-depressive effect.
psychiatry
What problem does this paper attempt to address?
### What problems does this paper attempt to solve? This paper aims to explore the improvement mechanism of 1 - methyltryptophan (1 - MT) on depressive - like behaviors in a high - fat diet (HFD) - induced mouse obesity model. Specifically, the researchers focus on the following points: 1. **The relationship between high - fat diet and depression**: Studies have shown that long - term high - fat diet intake can induce depressive - like behaviors in mice, accompanied by a reduction in hippocampal volume. However, the underlying mechanism is still unclear. 2. **The mechanism of action of 1 - MT**: 1 - MT is an IDO inhibitor and has been proven to reduce the production of Kyn metabolites by inhibiting IDO activity, thereby exerting an antidepressant effect. However, in this study, 1 - MT was able to improve HFD - induced depressive - like behaviors without significantly changing IDO levels, suggesting the existence of other potential mechanisms. 3. **Changes in the extracellular matrix (ECM) and perineuronal nets (PNNs)**: Through RNA - sequencing analysis, the researchers found that after 1 - MT treatment, the gene expression related to ECM tissue in HFD - induced depressive - like mice changed significantly. Further research focused on PNNs. These structures are mainly wrapped around inhibitory interneurons containing parvalbumin (PV) and are involved in the regulation of multiple neural functions. HFD led to excessive accumulation of PNNs, affecting the synaptic transmission of PV - positive neurons, which in turn led to glutamate - γ - aminobutyric acid (GABA) imbalance. And 1 - MT can effectively reverse these changes. ### Summary of the main research questions This study attempts to answer the following key questions: - How does high - fat diet induce depressive - like behaviors and what are the specific mechanisms behind it? - Can 1 - MT improve HFD - induced depressive - like behaviors? If so, what are the specific mechanisms? - What is the role of PNNs in HFD - induced depressive - like behaviors and what is the relationship between it and the therapeutic effect of 1 - MT? Through these explorations, the researchers hope to reveal new mechanisms by which 1 - MT improves HFD - induced depression, especially changes related to PNNs, and provide a theoretical basis for the development of new antidepressant treatment methods. ### Formula examples (if required) Since the content of this article involves the fields of biology and neuroscience, there are few formulas. If involved, they will be presented in Markdown format. For example: - The ratio change of glutamate and GABA can be expressed by the following formula: \[ \text{Glutamate - GABA Ratio}=\frac{\text{Glutamate Level}}{\text{GABA Level}} \] If you have more specific questions or need further information, please feel free to let us know!